New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
New research shows which ovarian cancer patients won't benefit from immune-PARP combo

New research shows which ovarian cancer patients won't benefit from immune-PARP combo

byDana-Farber Cancer InstituteIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (r
World medicine December 09,2023
New research shows which ovarian cancer patients won't benefit from immune-PARP combo

New research shows which ovarian cancer patients won't benefit from immune-PARP combo

byDana-Farber Cancer InstituteIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithelium (r
World medicine December 09,2023
Research identifies critical protein in cancer treatment-related heart damage

Research identifies critical protein in cancer treatment-related heart damage

by Judith VanDongen,Washington State UniversitySenior author and assistant professor Zhaokang Cheng (left) discusses an experiment with first author and postdoctoral research fellow Peng X
World medicine December 09,2023
Research identifies critical protein in cancer treatment-related heart damage

Research identifies critical protein in cancer treatment-related heart damage

by Judith VanDongen,Washington State UniversitySenior author and assistant professor Zhaokang Cheng (left) discusses an experiment with first author and postdoctoral research fellow Peng X
World medicine December 09,2023
Inherited mutation can predispose children to a type of brain tumor

Inherited mutation can predispose children to a type of brain tumor

bySt. Jude Children's Research HospitalCollaboration co-led by researchers at St. Jude Children's Research Hospital discovers a novel predisposition gene in pediatric medulloblastoma. Le
World medicine December 09,2023
Inherited mutation can predispose children to a type of brain tumor

Inherited mutation can predispose children to a type of brain tumor

bySt. Jude Children's Research HospitalCollaboration co-led by researchers at St. Jude Children's Research Hospital discovers a novel predisposition gene in pediatric medulloblastoma. Le
World medicine December 09,2023
Oral apixaban as good as dalteparin for treating cancer-associated clots

Oral apixaban as good as dalteparin for treating cancer-associated clots

byAmerican College of CardiologyCredit: CC0 Public DomainFor people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by i
World medicine December 09,2023
Oral apixaban as good as dalteparin for treating cancer-associated clots

Oral apixaban as good as dalteparin for treating cancer-associated clots

byAmerican College of CardiologyCredit: CC0 Public DomainFor people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by i
World medicine December 09,2023
Cellular protein shredders for the fight against cancer

Cellular protein shredders for the fight against cancer

byUniversity of BonnNumerous synthesis steps have to be carried out until a PROTAC molecule is produced (in the background). Prof. Dr. Michael Gütschow (left) and Christian Steinebach (right) fr
World medicine December 09,2023
Cellular protein shredders for the fight against cancer

Cellular protein shredders for the fight against cancer

byUniversity of BonnNumerous synthesis steps have to be carried out until a PROTAC molecule is produced (in the background). Prof. Dr. Michael Gütschow (left) and Christian Steinebach (right) fr
World medicine December 09,2023
Eye and the scalpel: Ocular tumors easier to diagnose noninvasively

Eye and the scalpel: Ocular tumors easier to diagnose noninvasively

by CNBPCredit: CNBPAustralia is the sunniest continent on Earth—which is why it also has the highest rates of skin cancer. But plentiful sunlight is also likely responsible for the lesser known ocular
World medicine December 09,2023
Eye and the scalpel: Ocular tumors easier to diagnose noninvasively

Eye and the scalpel: Ocular tumors easier to diagnose noninvasively

by CNBPCredit: CNBPAustralia is the sunniest continent on Earth—which is why it also has the highest rates of skin cancer. But plentiful sunlight is also likely responsible for the lesser known ocular
World medicine December 09,2023
Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers

Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainA study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity
World medicine December 09,2023
Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers

Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainA study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity
World medicine December 09,2023
Researchers identify molecular pathway that controls immunosuppression in tumors

Researchers identify molecular pathway that controls immunosuppression in tumors

byH. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainAn active immune system plays an important role in stopping cancer progression by identifying tumor cells and targ
World medicine December 09,2023
Researchers identify molecular pathway that controls immunosuppression in tumors

Researchers identify molecular pathway that controls immunosuppression in tumors

byH. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainAn active immune system plays an important role in stopping cancer progression by identifying tumor cells and targ
World medicine December 09,2023
Researchers produce potential true theranostic agent for cancer

Researchers produce potential true theranostic agent for cancer

byAustralian Nuclear Science and Technology Organisation (ANSTO)Credit: CC0 Public DomainThe therapeutic radioisotope scandium-47 has been produced for the first time in Australia by the Bioscie
World medicine December 09,2023
Researchers produce potential true theranostic agent for cancer

Researchers produce potential true theranostic agent for cancer

byAustralian Nuclear Science and Technology Organisation (ANSTO)Credit: CC0 Public DomainThe therapeutic radioisotope scandium-47 has been produced for the first time in Australia by the Bioscie
World medicine December 09,2023
Case study: Treating COVID-19 in a patient with multiple myeloma

Case study: Treating COVID-19 in a patient with multiple myeloma

byAmerican Society of HematologyCredit: CC0 Public DomainA case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for ver
World medicine December 09,2023
Case study: Treating COVID-19 in a patient with multiple myeloma

Case study: Treating COVID-19 in a patient with multiple myeloma

byAmerican Society of HematologyCredit: CC0 Public DomainA case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for ver
World medicine December 09,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com